Transcription Factor AP-2γ Stimulates Proliferation and Apoptosis and Impairs Differentiation in a Transgenic Model

Molecular Cancer Research

Volumn 1, Issue 12, 2003, Pages 921-929

  Jäger, Richard ^a   Werling, Uwe ^b,c   Rimpf, Stephan ^c   Jacob, Andrea ^a   Schorle, Hubert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE TARGETING; IMMUNOREACTIVITY; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN MOTIF; SEMINAL VESICLE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; PREGNANCY; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; UP-REGULATION;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS;

EID: 0142120585     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zhao, F., Satoda, M., Licht, J. D., Hayashizaki, Y., and Gelb, B. D. Cloning and characterization of a novel mouse ap-2 transcription factor, ap-2δ, with unique DNA binding and transactivation properties. J. Biol. Chem., 276: 40755-40760, 2001.
2. Hilger-Eversheim, K., Moser, M., Schorle, H., and Buettner, R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene, 260: 1-12, 2000.
3. Williams, T. and Tjian, R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev., 5: 670-682, 1991.
4. Williams, T. and Tjian, R. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science, 251: 1067-1071, 1991.
5. Schorle, H., Meier, P., Buchert, M., Jaenisch, R., and Mitchell, P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature, 381: 235-238, 1996.
6. Moser, M., Pscherer, A., Roth, C., Becker, J., Mucher, G., Zerres, K., Dixkens, C., Weis, J., Guay-Woodford, L., Buettner, R., and Fassler, R. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev., 11: 1938-1948, 1997.
7. Zhang, J., Hagopian-Donaldson, S., Serbedzija, G., Elsemore, J., Plehn-Dujowich, D., McMahon, A. P., Flavell, R. A., and Williams, T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature, 381: 238-241, 1996.
8. Werling, U. and Schorle, H. Transcription factor gene AP-2γ essential for early murine development. Mol. Cell. Biol., 22: 3149-3156, 2002.
9. Pfisterer, P., Ehlermann, J., Hegen, M., and Schorle, H. A subtractive gene expression screen suggests a role of transcription factor AP-2 α in control of proliferation and differentiation. J. Biol. Chem., 277: 6637-6644, 2002.
10. Bosher, J. M., Williams, T., and Hurst, H. C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA, 92: 744-747, 1995.
11. Williamson, J. A., Bosher, J. M., Skinner, A., Sheer, D., Williams, T., and Hurst, H. C. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics, 35: 262-264, 1996.
12. Hynes, N. E. and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
13. Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T., and Hurst, H. C. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene, 13: 1701-1707, 1996.
14. Perissi, V., Menini, N., Cottone, E., Capello, D., Sacco, M., Montaldo, F., and De Bortoli, M. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen. Oncogene, 19: 280-288, 2000.
15. Turner, B. C., Zhang, J., Gumbs, A. A., Maher, M. G., Kaplan, L., Carter, D., Glazer, P. M., Hurst, H. C., Haffy, B. G., and Williams, T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res., 58: 5466-5472, 1998.
16. McPherson, L. A., Baichwal, V. R., and Weigel, R. J. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. USA, 94: 4342-4347, 1997.
17. Gee, J. M., Robertson, J. F., Ellis, I. O., Nicholson, R. I., and Hurst, H. C. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J. Pathol., 189: 514-520, 1999.
18. Munarini, N., Jager, R., Abderhalden, S., Zuercher, G., Rohrbach, V., Loercher S., Pfanner-Meyer, B., Andres, A. C., and Ziemiecki, A. Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J. Cell Sci., 115: 25-37, 2002.
19. Rosemblit, N. and Chen, C. L. Regulators for the rat clusterin gene: DNA methylation and cis-acting regulatory elements. J. Mol. Endocrinol., 13: 69-76, 1994.
20. Duan, C. and Clemmons, D. R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem., 270: 24844-24851, 1995.
21. Marshman, E., Green, K. A., Flint, D. J., White, A., Streuli, C. H., and Westwood, M. Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J. Cell Sci., 116: 675-682, 2003.
22. Tonner, E., Barber, M. C., Allan, G. J., Beattie, J., Webster, J., Whitelaw, C. B., and Flint, D. J. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development, 129: 4547-4557, 2002.
23. Zhang, J., Brewer, S., Huang, J., and Williams, T. Overexpression of transcription factor AP-2α suppresses mammary gland growth and morphogenesis. Dev. Biol., 256: 127-145, 2003.
24. Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P., and Leder, P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J., 9: 907-913, 1990.
25. Kitsberg, D. I., and Leder, P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene, 13: 2507-2515, 1996.
26. Pelengaris, S., Khan, M., and Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer, 2: 764-776, 2002.
27. Burdon T. S. L., Wall, R. J., Spencer, M., Hogan, B., Constantini, F., and Lacy, E. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Press, 1996.
28. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
29. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685, 1970.